Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
4.060
-0.050 (-1.22%)
Nov 25, 2025, 4:00 PM EST - Market closed
Aethlon Medical Market Cap
Aethlon Medical has a market cap or net worth of $3.09 million as of November 26, 2025. Its market cap has decreased by -44.80% in one year.
Market Cap
3.09M
Enterprise Value
-2.22M
1-Year Change
-44.80%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since July 13, 2015, Aethlon Medical's market cap has decreased from $68.00M to $3.09M, a decrease of -95.45%. That is a compound annual growth rate of -25.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 3.10M | -74.17% |
| Dec 31, 2024 | 12.00M | 118.18% |
| Dec 29, 2023 | 5.50M | -12.70% |
| Dec 30, 2022 | 6.30M | -77.97% |
| Dec 31, 2021 | 28.60M | -4.35% |
| Dec 31, 2020 | 29.90M | 2,035.71% |
| Dec 31, 2019 | 1.40M | -95.27% |
| Dec 31, 2018 | 29.60M | 73.10% |
| Dec 29, 2017 | 17.10M | -47.38% |
| Dec 30, 2016 | 32.50M | -37.14% |
| Dec 31, 2015 | 51.70M | -23.97% |
| Jul 13, 2015 | 68.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |